Market Overview

Mirati Therapeutics (NASDAQ: MRTX)

189.04 -5.85 (-3.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/16/20HC Wainwright & Co.MaintainsBuy222.0
10/08/20Credit SuisseReiteratesOutperform190.0
9/28/20B of A SecuritiesInitiates Coverage OnNeutral172.0
9/21/20Piper SandlerMaintainsOverweight170.0
9/21/20OppenheimerMaintainsOutperform190.0
9/18/20CitigroupDowngradesNeutral183.0
9/17/20HC Wainwright & Co.MaintainsBuy185.0
8/07/20Credit SuisseMaintainsOutperform140.0
7/29/20Credit SuisseMaintainsOutperform135.0
5/01/20JP MorganUpgradesOverweight

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter